Study rationale and design of the EANITIATE study (EmpAgliflozin compared to NPH Insulin for sTeroId diAbeTEs) - a randomized, controlled, multicenter trial of safety and efficacy of treatment with empagliflozin compared with NPH-insulin in patients with newly onset diabetes following initiation of glucocorticoid treatment

BACKGROUND: A well-known metabolic side effect from treatment with glucocorticoids is glucocorticoid-induced diabetes mellitus (GIDM). Guidelines on the management of GIDM in hospitalized patients (in the non-critical care setting), recommend initiation of insulin therapy. The scientific basis and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Klarskov, Carina Kirstine, Holm Schultz, Helga, Persson, Frederik, Møller Christensen, Tomas, Almdal, Thomas Peter, Snorgaard, Ole, Bagge Hansen, Katrine, Pedersen-Bjergaard, Ulrik, Lommer Kristensen, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296645/
https://www.ncbi.nlm.nih.gov/pubmed/32539810
http://dx.doi.org/10.1186/s12902-020-00561-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296645/
https://www.ncbi.nlm.nih.gov/pubmed/32539810
http://dx.doi.org/10.1186/s12902-020-00561-0

Ejemplares similares